The Latin America, Middle East and Africa Interventional Cardiology Devices Market would witness market growth of 9.9% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 6,207.6 thousand units, showcasing a growth of 11.9% (2023-2030).
Interventional surgeries require specialized equipment to repair damaged or compromised blood vessels, constricted arteries, or other affected portions of the heart's structure non-surgically. As a result, cardiac catheterization labs or hospitals use interventional cardiology tools, including cutting balloon catheters, coronary stents, and percutaneous transluminal coronary angioplasty, to undertake minimally invasive procedures. The prevalence of cardiovascular diseases (CVDs), including atrial fibrillation, coronary heart disease, and stroke, is rising. Environmental risk factors, such as pollution, and biological risk factors, such as alcohol consumption, improper diet, tobacco use, and smoking, among others, are to blame for the increase in cardiovascular disease incidence.
In addition, healthcare providers are placing a greater emphasis on shorter hospital stays and fewer postoperative complications. This is causing a rise in minimally invasive interventional cardiovascular interventions. Consequently, these factors have increased the demand for various cardiac procedures. Furthermore, the advantages offered by minimally invasive cardiac procedures, such as smaller incisions, rapid recovery, and lower infection rates compared to other heart surgeries, are responsible for the increasing recommendation of minimally invasive cardiac procedures by healthcare professionals to patients.
The UAE has adopted state-of-the-art imaging technologies for interventional cardiology procedures, including fluoroscopy, angiography, and intravascular ultrasound (IVUS). These technologies provide detailed real-time images of the heart and blood vessels, aiding in precise diagnosis and treatment planning. Three-dimensional (3D) and four-dimensional (4D) imaging techniques have been increasingly used in the UAE for cardiac catheterization and electrophysiology procedures. These technologies offer improved visualization of complex cardiac structures. Continued healthcare infrastructure, research, and technology investment will expand the region’s market.
The Brazil market dominated the LAMEA Interventional Cardiology Devices Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $416.2 million by 2030. The Argentina market is showcasing a CAGR of 10.5% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 9.6% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers & Others. Based on Product, the market is segmented into Coronary Stents (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents), Accessory Devices (PTCA Guidewires, Diagnostic Catheters, PTCA Guiding Catheters, Introducer Sheaths), PTCA Balloon Catheters (Normal, Specialty, Drug Coated), Intravascular Imaging Catheters & Pressure Guidewires. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Medtronic PLC, B. Braun Melsungen AG, Biotronik SE & Co. KG, Cardinal Health, Inc., Teleflex, Inc., Koninklijke Philips N.V., Alvimedica.
Interventional surgeries require specialized equipment to repair damaged or compromised blood vessels, constricted arteries, or other affected portions of the heart's structure non-surgically. As a result, cardiac catheterization labs or hospitals use interventional cardiology tools, including cutting balloon catheters, coronary stents, and percutaneous transluminal coronary angioplasty, to undertake minimally invasive procedures. The prevalence of cardiovascular diseases (CVDs), including atrial fibrillation, coronary heart disease, and stroke, is rising. Environmental risk factors, such as pollution, and biological risk factors, such as alcohol consumption, improper diet, tobacco use, and smoking, among others, are to blame for the increase in cardiovascular disease incidence.
In addition, healthcare providers are placing a greater emphasis on shorter hospital stays and fewer postoperative complications. This is causing a rise in minimally invasive interventional cardiovascular interventions. Consequently, these factors have increased the demand for various cardiac procedures. Furthermore, the advantages offered by minimally invasive cardiac procedures, such as smaller incisions, rapid recovery, and lower infection rates compared to other heart surgeries, are responsible for the increasing recommendation of minimally invasive cardiac procedures by healthcare professionals to patients.
The UAE has adopted state-of-the-art imaging technologies for interventional cardiology procedures, including fluoroscopy, angiography, and intravascular ultrasound (IVUS). These technologies provide detailed real-time images of the heart and blood vessels, aiding in precise diagnosis and treatment planning. Three-dimensional (3D) and four-dimensional (4D) imaging techniques have been increasingly used in the UAE for cardiac catheterization and electrophysiology procedures. These technologies offer improved visualization of complex cardiac structures. Continued healthcare infrastructure, research, and technology investment will expand the region’s market.
The Brazil market dominated the LAMEA Interventional Cardiology Devices Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $416.2 million by 2030. The Argentina market is showcasing a CAGR of 10.5% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 9.6% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers & Others. Based on Product, the market is segmented into Coronary Stents (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents), Accessory Devices (PTCA Guidewires, Diagnostic Catheters, PTCA Guiding Catheters, Introducer Sheaths), PTCA Balloon Catheters (Normal, Specialty, Drug Coated), Intravascular Imaging Catheters & Pressure Guidewires. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Medtronic PLC, B. Braun Melsungen AG, Biotronik SE & Co. KG, Cardinal Health, Inc., Teleflex, Inc., Koninklijke Philips N.V., Alvimedica.
Scope of the Study
Market Segments Covered in the Report:
By End Use (Volume, Thousand Units, USD Million, 2019-2030)- Hospitals & Clinics
- Ambulatory Surgical Centers & Others
- Coronary Stents
- Drug Eluting Stents
- Bare Metal Stents
- Bioabsorbable Stents
- Accessory Devices
- PTCA Guidewires
- Diagnostic Catheters
- PTCA Guiding Catheters
- Introducer Sheaths
- PTCA Balloon Catheters
- Normal
- Specialty
- Drug Coated
- Intravascular Imaging Catheters & Pressure Guidewires
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Boston Scientific Corporation
- Terumo Corporation
- Medtronic PLC
- B.Braun Melungeon AG
- Bortnick SE & Co. KG
- Cardinal Health, Inc.
- Teleflex, Inc.
- Koninklijke Philips N.V.
- Alvimedica
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. LAMEA Interventional Cardiology Devices Market by End-use
Chapter 6. LAMEA Interventional Cardiology Devices Market by Product
Chapter 7. LAMEA Interventional Cardiology Devices Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Abbott Laboratories
- Boston Scientific Corporation
- Terumo Corporation
- Medtronic PLC
- B. Braun Melungeon AG
- Bortnick SE & Co. KG
- Cardinal Health, Inc.
- Teleflex, Inc.
- Koninklijke Philips N.V.
- Alvimedica
Methodology
LOADING...
